Tools for Practice Outils pour la pratique


#386 The Bland Supremacy: Salt and cardiovascular disease


CLINICAL QUESTION
QUESTION CLINIQUE
Does reducing sodium intake or substituting table salt with sodium-potassium alternatives improve cardiovascular outcomes?


BOTTOM LINE
RÉSULTAT FINAL
Based on one large randomized, controlled trial (RCT) in patients with hypertension/previous stroke with above average daily salt intake (example 4.8 g/day), replacing table salt with a salt substitute may decrease mortality (from ~4.5% to ~4%) and stroke (from ~3.5% to 3%) per year. Whether reducing sodium by other means reduces mortality or cardiovascular events is unknown.



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
  • Results statistically significant unless indicated.
  • Table salt substitution (75% sodium-chloride/25% potassium-chloride), largest RCT:1
    • 20,995 participants from rural China (age ~65, mean blood pressure ~154/89, 73% with stroke history, sodium intake ~4.8g at baseline),2 estimated incidence per year:
      • Mortality: ~4% (salt substitution) versus ~4.5 % (usual salt), Number Needed to Treat (NNT)=200.
      • Strokes: ~3% (salt substitution) versus ~3.4 % (usual salt), NNT=250.
      • Systolic blood pressure: Reduced by 3.3mmHg (salt substitution) compared to continuing regular salt.
      • Limitation: Likely higher than average salt intake.
  • Four systematic reviews (including above trial) showed similar results for mortality.3-6
  • Adverse effects:
    • Serum potassium: 0.12-0.18mmol/L higher with salt substitution.3,6
    • Overall, few cases severe hyperkalemia/worsening renal function. 3,6
    • Limitations: Severe kidney disease excluded.1
  • Sodium reduction: No RCT powered to detect change in mortality/cardiovascular events.7,8

CONTEXT
CONTEXTE
  • Guidelines:
    • Recommend sodium reduction (example: <2g/day) but there is no reliable way for patients to estimate sodium consumption.9
    • Average sodium intake (Canadians): ~2.7-3.6g/day.10,11
  • In Canada, 75% sodium-chloride/25% potassium-chloride not available. Products with different blends of salt and potassium chloride (containing 50% less sodium than regular salt) are available (example: Half-SaltTM).
  • Blood pressure:
    • RCT: Lowering sodium intake (~3.6 to ~2.6 grams/day) reduces BP by ~4mmHg at 2.5 years.7,8 However, this was achieved with coaching to reduce sodium; unknown if brief interventions/self-help materials helpful long-term.
    • Effect of sodium substitution/reduction on blood pressure is comparable to blood-pressure medications.12
  • If processed food important source of sodium intake (common in North America, but not rural China), salt substitution/reduction may have less impact.
  • Focusing on healthier food choices important; the Mediterranean diet has been shown to reduce the risk of cardiovascular events.13


Jeffrey Sloan March 31, 2025

Confirms my current practice

Anwar Abu Dieh April 2, 2025

Good topic


Latest Tools for Practice
Derniers outils pour la pratique

#386 The Bland Supremacy: Salt and cardiovascular disease

Does reducing sodium intake or substituting table salt with sodium-potassium alternatives improve cardiovascular outcomes?
Read Lire 0.25 credits available Crédits disponibles

#385 Topical minoxidil for androgenetic alopecia: When blood pressure agents make you hairy

How effective is topical minoxidil for androgenetic alopecia?
Read Lire 0.25 credits available Crédits disponibles

#384 Treatment of PTSD Nightmares: Is prazosin a dream come true?

How effective is prazosin for nightmares in posttraumatic stress disorder (PTSD)?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • Émélie Braschi MD PhD CCFP
  • Jennifer Young MD CCFP-EM

1. Neal B, Wu Y, Feng X et al. N Engl J Med. 2021 Sep 16;385(12):1067-1077.

2. Yin X, Paige E, Tian M et al. Hypertension. 2023 May;80(5):956-965.

3. Greenwood H, Barnes K, Clark J et al. Ann Intern Med. 2024 May;177(5):643-655.

4. Yin X, Rodgers A, Perkovic A et al. Heart. 2022 Sep 26;108(20):1608-1615.

5. Tsai YC, Tsao YP, Huang CJ et al. J Clin Hypertens (Greenwich). 2022 Sep;24(9):1147-1160.

6. Brand A, Visser ME, Schoonees A et al. Cochrane Database of Syst Rev 2022, Aug 10;8(8):CD015207.

7. Adler A, Taylor F, Martin N et al. Cochrane Database Syst Rev. 2014 Dec 18;2014(12):CD009217.

8. Whelton PK, Appel LJ, Espeland WB et al. JAMA. 1998 Mar 18;279(11):839-46.

9. O’Donnell M, Mente A, Alderman M et al. Eur Heart J. 2020 Sep 14;41(35):3363-3373.

10. Sodium Intake of Canadians in 2017. Health Canada. Available online at https://www.canada.ca/content/dam/hc-sc/documents/services/publications/food-nutrition/sodium-intake-canadians-2017/2017-sodium-intakes-report-eng.pdf. Accessed September 18-2024.

11. Mean salt intake in adults aged 25 years and older in the Americas, 1990-2019. ENLACE Data Portal. Pan American Health Organization, 2023. Available online at https://www.paho.org/en/enlace/salt-intake. Accessed September 18-2024.

12. McLean R. Cochrane Database Syst Rev. 2022 Aug 18;8(8):ED000158.

13. Kolber MR, Klarenbach S, Cauchon M et al. Canadian Family Physician. 2023 Oct;69(10)675-686.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.